Sort
25,944 grants matching “neurodegeneration”
Identifying Regulators of Degeneration due to Defective Mitochondrial DNA
$764,554Ming Guo · University Of California Los Angeles · R01 · FY2021 · AG
Hypertension, brain clearance and markers of neurodegeneration
$764,525Lidia Glodzik · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · NS
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease
$764,472Srikant Rangaraju · Yale University · R01 · FY2024 · AG
PASK-regulated genes and proteins as therapeutic targets for ALS and FTD
$764,464Daniel R Scoles · Utah State Higher Education System--University Of Utah · R01 · FY2025 · NS
Physical exercise and Blood-brain communication: exosomes, Klotho and choroid plexus
$764,075Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Investigating Resistance and Resilience Mechanisms in Alzheimerâs Disease
$764,047Prashanthi Vemuri · Mayo Clinic Rochester · R01 · FY2025 · AG
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease
$763,880Thomas Spurgeon Wingo · Emory University · R01 · FY2022 · AG
Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD
$763,872Adam Peter Spira · Johns Hopkins University · R01 · FY2021 · AG
Compartmentalized CSF viral escape and the CNS HIV reservoir
$763,785Richard W Price · University Of California, San Francisco · R01 · FY2015 · NS
Dorsal Column Stimulation as a New Therapy for Motor Disorders
$763,675Miguel A. L. Nicolelis · Duke University · R01 · FY2011 · NS
Dorsal Column Stimulation as a New Therapy for Motor Disorders
$763,392Miguel A. L. Nicolelis · Duke University · R01 · FY2012 · NS
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes
$763,277Jennifer Louise Whitwell · Mayo Clinic Rochester · R01 · FY2020 · NS
Epigenomic analysis of neural circuits in Alzheimer's disease mouse models
$763,246Xiangmin Xu · University Of California-Irvine · R01 · FY2021 · AG
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
$763,151Peng Jin · Emory University · R01 · FY2023 · AG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$763,089Elizabeth Head · University Of Kentucky · R01 · FY2017 · AG
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArTâÂÂHS)
$763,006Gregory A Jicha · University Of Kentucky · R01 · FY2019 · AG
The role of autophagy in aging and metabolism
$762,914Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
The biology of the sirtuins
$762,914Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Novel pathogenic mechanism of HIV-associated CNS neurological disorders
$762,862Michael Ilya Bukrinsky · George Washington University · R01 · FY2023 · NS
Dorsal Column Stimulation as a New Therapy for Motor Disorders
$762,860Miguel A. L. Nicolelis · Duke University · R01 · FY2014 · NS
Integrated Platform to study Neurodegeneration in Alzheimerâs Disease
$762,780Judith A Steen · Boston Children'S Hospital · R01 · FY2025 · AG
HABS-HD - Core F - Biostatistics Core
$762,438Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2025 · AG
Shared Mechanisms of Tau Toxicity Among Neurodegenerative Diseases
$762,144Bingwei Lu · Stanford University · R01 · FY2025 · AG
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease
$762,048Peter M Tessier · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
Yale Cellular Neuroscience, Neurodegeneration and Repair (CNNR) Program
$762,000Stephen M Strittmatter · Yale University · P30 · FY2009 · NS